Sebastiano
Gangemi
Email: 
sebastiano.gangemi@unime.it

ALTRE INFORMAZIONI

SSD: MED/09
Profilo: Professori Ordinari

CURRICULUM

Curriculum

PROF. SEBASTIANO GANGEMI
 
PROFESSORE ORDINARIO MED/09
MEDICINA INTERNA
 
 
 
DIRETTORE DELLA SCUOLA DI SPECIALIZZAZIONE  DI ALLERGOLOGIA E IMMUNOLOGIA CLINICA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
UNIVERSITA’ DEGLI STUDI DI MESSINA
 
 
DIRETTORE DELLA U.O.S.D.  DI ALLERGOLOGIA E IMMUNOLOGIA CLINICA
DIPARTIMENTO DI SCIENZE MEDICHE
A.O.U. POLICLINICO “G. MARTINO” DI MESSINA
CURRICULUM ACCADEMICO
 
LAUREA
Il Prof. Sebastiano Gangemi, in data 16/07/1992 ha conseguito la Laurea in Medicina e Chirurgia presso l'Università di Messina con la votazione di 110/110 e lode accademica.
 
SPECIALIZZAZIONE
In data 21/10/1996 ha conseguito il Diploma di Specializzazione in Allergologia e Immunologia Clinica presso la Facoltà di Medicina e Chirurgia dell'Università di Messina con la votazione di 50/50 e lode accademica, discutendo la tesi "Nickel ed alimenti".
 
Nell'Anno Accademico 1995-96 ha ricevuto il premio Lofarma per la migliore tesi di Specializzazione in Allergologia e Immunologia Clinica.
 
 In data 13/10/1997 ha conseguito il Diploma del Corso di Perfezionamento post-Universitario in Rischi e Patologia nel Lavoro presso la Facoltà di Medicina e Chirurgia di Messina con la votazione di 50/50 e lode accademica, discutendo la tesi "Inquinamento atmosferico e allergopatie respiratorie".
 
DOTTORATO DI RICERCA
In data 25/02/2002 ha conseguito il Dottorato di Ricerca in Medicina Sperimentale discutendo la tesi "Ruolo delle citochine nella patogenesi dell'asma bronchiale allergica".
 
RICERCATORE UNIVERSITARIO IN MEDICINA INTERNA
Nel 2001 ha vinto il concorso per Ricercatore universitario in Medicina Interna (settore scientifico disciplinare MED09), e, con questa qualifica, ha preso servizio in data 25/06/2001 presso l’U.O. di Allergologia e Immunologia Clinica del Dipartimento di Patologia Umana del Policlinico Universitario di Messina, dove attualmente presta servizio.
 
COLLEGIO GIUNTA DIPARTIMENTO
Il 24/11/2004 è stato eletto tra i componenti della Giunta del Consiglio di Dipartimento di Patologia Umana della Facoltà di Medicina e Chirurgia dell’Università di Messina.
Il 13/11/2013 è stato eletto tra i componenti della Giunta del Consiglio di Dipartimento di Medicina Clinica e Sperimentale dell’Università di Messina.
 
PROFESSORE ASSOCIATO IN MEDICINA INTERNA
Nel Dicembre 2005 ha vinto il concorso per Professore Associato in Medicina Interna (settore scientifico disciplinare MED09) (DR 30/12/05), e, con questa qualifica, ha preso servizio in data 03/02/2006 presso l’U.O.C. di Allergologia e Immunologia Clinica del Dipartimento di Patologia Umana del Policlinico Universitario di Messina,
 
Il 31/08/09 è stato confermato, con Decreto Rettorale, Professore Associato.
Dall’8 Maggio 2006 al 31 Dicembre 2006 è stato Responsabile dell’Ambulatorio di Allergologia presso la Divisione di Allergologia e Immunologia Clinica dell'Università di Messina.
 
PROFESSORE ORDINARIO IN MEDICINA INTERNA
Dal 28 Dicembre 2021 Professore Ordinario di Medicina Interna (settore scientifico disciplinare MED09) presso l’ Università degli Studi di Messina

DIRETTORE SCUOLA DI SPECIALIZZAZIONE IN ALLERGOLOGIA E IMMUNOLOGIA CLINICA
Il 10 Novembre 2006 è stato nominato, con Decreto Rettorale, Direttore della Scuola di Specializzazione in Allergologia e Immunologia Clinica della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina, incarico che tutt’ora ricopre.
 
GARANTE UNIVERSITA’ DEGLI STUDI DI MESSINA 2009-2011
Il 06 ottobre del 2009 è stato nominato, con Decreto Rettorale, nella Commissione dei tre garanti dell’Università di Messina per la durata di un biennio.
 
DIREZIONE DI UNITA’ OPERATIVE
Dal 1 Novembre 2008 al 29/06/09 ha avuto l’incarico temporaneo di Direttore della U.O.C. di Allergologia e Immunologia Clinica del Policlinico Universitario di Messina.
Con delibera del 23/06/09, a decorrere dal 29/06/09 sino al 31/12/2019 ha ricoperto l’incarico gestionale di Direttore della U.O.C. di Allergologia e Immunologia Clinica.
Dal 01/01/2020 ricopre l’incarico di Direttore di U.O.S.D. a seguito di trasformazione della U.O.C. di Allergologia e Immunologia Clinica in Struttura Semplice Dipartimentale per adeguamento del Piano Aziendale sulle indicazioni previste dal D.A. 22/2019 dell' Assessorato Regionale della Salute (Regione Sicilia).
Nel 2012 ha conseguito il Diploma del Corso di Formazione Manageriale per l’accesso agli incarichi relativi alle funzioni di direttore di Struttura Complessa.
 
 
ATTIVITA’ DI RICERCA PRESSO ALTRO ENTE
Dal 01/04/2003 al 30/09/2003 è stato in congedo per motivi di ricerca presso il laboratorio di Biologia Molecolare del Ce.S.I. (Centro di Eccellenza sull’Invecchiamento), Dipartimento di Scienze Biomediche, dell'Università G. D'Annunzio di Chieti nell'ambito di uno studio sulle modificazioni immunologiche in corso di invecchiamento
 
Dal 01/11/2003 al 30/10/2004 è stato nuovamente in congedo per motivi di ricerca presso il laboratorio di Biologia Molecolare del Ce.S.I. nell'ambito di uno studio sui meccanismi della risposta infiammatoria e della sua risoluzione.
 
CNR - ASSOCIATURA E COORDINAMENTO PROGETTI
Dal 14 Ottobre 2009 al 31 Dicembre 2015 ha ottenuto l’associatura presso l’IBIM (Istituto di Biomedicina e Immunologia Molecolare – CNR) del CNR.
Dall’Ottobre 2015 per un anno è stato associato presso L’ISASI (Institute of Applied Sciences and Intelligent Systems) del CNR (Consiglio Nazionale delle Ricerche).
Dal 01 gennaio 2020 associatura IRIB (Istituto di Ricerca e Innovazione in campo Biomedico) del CNR.
 
PUBBLICAZIONI INTERNAZIONALI  E PARAMETRI
E' autore di  367 lavori internazionali in lingua inglese in exstenso su riviste con impact factor;
possiede un indice H di 41 e 6047 citazioni su Scopus e un H di 49 e 8516 citazioni su Google Scholar.
Dal 2018 fa parte dei Top Italian Scientists (http://www.topitalianscientists.org) .
 
ORGANIZZAZIONE E PARTECIPAZIONE A  CONGRESSI
Ha partecipato, in qualità di relatore, ad oltre 130 Congressi in Italia ed all’Estero. Organizzatore di diversi congressi Nazionali della SIAAIC e dell’AIA.
 
DOCENZA CORSI DI LAUREA, SCUOLE DI SPECIALIZZAZIONE E DOTTORATI DI RICERCA
Attualmente è docente presso 2 Corsi di Laurea dell’Università di Messina (Corso di Laurea in Medicina e Chirurgia, Corso di Laurea in Scienze Motorie, Sport e Salute), 1 Dottorato di Ricerca in Translational Molecular Medicine and Surgery, ed in 3 Scuole di Specializzazione.
Dall’Anno Accademico 2001/2002 è docente presso il Corso di Laurea in Medicina e Chirurgia presso l’Università di Messina, insegnamento in Allergologia e Immunologia Clinica.
Dall’Anno Accademico 2015/2016 è docente presso il Corso di Laurea in Scienze Motorie, Sport e Salute presso l’Università di Messina, insegnamento di Principi di Medicina Applicata alle Scienze Motorie I.
Nell’Anno Accademico 2004/2005 ha fatto parte del Collegio dei Docenti del Dottorato di Ricerca in “Invecchiamento: demografia, biologia e clinica”, XX ciclo.
Dall’Anno Accademico 2010/2011 al 2012/2013 ha fatto parte del Collegio dei Docenti del Dottorato di Ricerca in “Ricerca clinica e traslazionale nella terapia in-tensiva della sindrome cardio-renale e del trapianto di rene”. 
Dall’Anno Accademico 2013/2014 al 2017/2018 componente del Collegio dei Docenti del Dottorato di Ricerca in Scienze Biomediche Cliniche e Sperimentali .
Dal 12/03/2019 componente del Collegio dei Docenti del Dottorato in Translational Molecular Medicine and Surgery.
Dall'Anno Accademico 2001/2002 gli sono stati conferiti i seguenti incarichi di insegnamento presso la Scuola di Specializzazione in Allergologia e Immunologia Clinica della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
  • Diagnostica Allergologica e Immunologica “in vivo” I (I anno)
  • Diagnostica Allergologica e Immunologica “in vivo” III (IV anno)
Dall’Anno Accademico 2004/2005 ha avuto i seguenti incarichi presso la Scuola di Specializzazione in Allergologia e Immunologia Clinica della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
  • Metodologia e Semeiotica allergologica I (I anno)
  • Diagnostica allergologica e immunologica “in vivo” II (IV anno)
Dall'Anno Accademico 2004/2005 ad oggi gli é stato conferito il seguente incarico di insegnamento presso la Scuola di Specializzazione in Farmacia Ospedaliera della Facoltà di Farmacia dell’Università degli Studi di Messina:
  • Immunologia
Dall'Anno Accademico 2004/2005  al 2010/2011 gli é stato conferito il seguente incarico di insegnamento presso la Scuola di Specializzazione in Genetica Pediatrica della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
  • Immunologia
Dall’Anno Accademico 2001/2002, fa parte dei docenti del “Corso Integrato di Allergologia ed Immunologia Clinica e Reumatologia” al Corso di Laurea in Medicina e Chirurgia dell’Università degli Studi di Messina
Dall'Anno Accademico 2005/2006 al 2017/2018 gli é stato conferito il seguente incarico di insegnamento presso la Scuola di Specializzazione in Ginecologia e Ostetricia della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
      -      Immunologia della gravidanza
 Dall'Anno Accademico 2008/209 al 2015/2016 gli é stato conferito il seguente incarico di insegnamento presso la Scuola di Specializzazione in Reumatologia della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
  • Immunologia clinica
Dall'Anno Accademico 2009/2010 al 2014/2015 gli é stato conferito il seguente incarico di insegnamento presso la Scuola di Specializzazione in Medicina dello Sport della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
      -    Immunologia clinica
Dall'Anno Accademico 2012/2013 ad oggi gli é stato conferito il seguente incarico di insegnamento presso la Scuola di Specializzazione in Pediatria della Facoltà di Medicina e Chirurgia dell’Università degli Studi di Messina:
  • Immunologia
 
COORDINAMENTO CORSI INTEGRATI
Dall’anno accademico 2019/20 Coordinatore del Corso Integrato in REUMATOLOGIA, ALLERGOLOGIA E IMMUNOLOGIA CLINICA del Corso di Laurea in Medicina e Chirurgia;
Dall’anno accademico 2019/20 Coordinatore del Corso Integrato in PRINCIPI DI MEDICINA APPLICATA ALLE SCIENZE MOTORIE I del Corso di Laurea in Scienze Motorie, Sport e Salute.
 
RESPONSABILE PROGRAMMA ERASMUS
Dal 24 Giugno 2019, è stato nominato “Responsabile della Mobilità Internazionale del Corso di Laurea in Scienze Motorie, Sport e Salute L 22 ” a far tempo dall’Anno Accademico 2019/20. In tale veste, svolge anche il ruolo di “Responsible person at the Sending/Receiving Institution” nel Programma ERASMUS + che il CdS ha attivato con diverse Sedi Universitarie Europee.
 
 
CONSIGLI DIRETTIVI NAZIONALI
Dall'Ottobre 2000 al Novembre 2002 è stato membro del Consiglio Direttivo Nazionale dell'AIA (Società Italiana di Aerobiologia)
Successivamente, dal Giugno 2003 ad Aprile 2006, ha ricoperto nuovamente la carica di membro del Consiglio Direttivo Nazionale dell'AIA
Da Aprile 2006 a Maggio 2009, ha ricoperto nuovamente la carica di membro del Consiglio Direttivo Nazionale dell'AIA per il triennio 2006/2009
Nell’Ottobre 2008, è stato eletto membro del Consiglio Direttivo Nazionale della SIAIC per il triennio 2008/2011.
Successivamente nel Maggio 2011 è stato rieletto nel Consiglio Direttivo Nazionale della SIAIC per il triennio 2011/2014.
Dal 2019 Membro del Direttivo Esecutivo, con la carica di Tesoriere, della Società Italiana di Allergologia, Asma e Immunologia Clinica.
 
EDITORIAL BOARD
Dal gennaio 2017 è Section Editor Di Clinical Molecular Allergy
Dal novembre 2019 è Section Editor della rivista Current Molecular Medicine
Dal 2020 fa parte dell’International Board della rivista Allergy and Asthma Proceedings
 
PREMI
Nell’Anno Accademico 1995/96 vinceva il premio LOFARMA per la migliore Tesi di Specializzazione in Allergologia e Immunologia Clinica dal titolo “Nickel e alimenti”.
Nell’anno 2016 vincitore del Premio “ALATA SOLERTIA” XXXIII Edizione conferito dal Movimento Nuova Presenza “Giorgio La Pira” .
 
COLLABORAZIONI CON ALTRI ENTI DI RICERCA NAZIONALI ED INTERNAZIONALI
 
ENTI DI RICERCA INTERNAZIONALI:
 
 
- University of Colorado Health Sciences Center - Department of Medicine, Division of Infectious Diseases – Denver – Colorado – USA
 
- Weizmann Institute of Science – Department of Molecular Genetics – Rehovot – Israele
 
ENTI DI RICERCA NAZIONALI:
  • Ce.S.I. (Centro di Eccellenza sull’Invecchiamento) - Dipartimento di Scienze Biomediche – Laboratorio di Medicina Molecolare – Università “G. D’Annunzio” – Chieti
  • I.N.R.C.A. (Italian National Research Center on Aging) – Ancona
  • IRCCS-CSS San Giovanni Rotondo, CSS Mendel – Roma
  • IBIM (Istituto di Biomedicina e Immunologia Molecolare) del CNR (Consiglio Nazionale delle Ricerche).
  • Institute of Clinical Physiology IFC, Messina Unit, Consiglio Nazionale delle Ricerche (CNR)
  • Fondazione “Stella Maris”
  • Institute of Applied Sciences and Intelligent Systems (ISASI), del CNR (Consiglio Nazionale delle Ricerche).
  • IRIB – CNR (Istituto di Ricerca e Innovazione in campo Biomedico), del CNR (Consiglio Nazionale delle Ricerche).
Pubblicazioni:
  1. Hmgb-1 in psoriasis
  2. Autism spectrum disorders and atopic dermatitis: a new perspective from country-based prevalence data
  3. Current take on systemic sclerosis patients’ vaccination recommendations
  4. Role of epithelium-derived cytokines in atopic dermatitis and psoriasis: Evidence and therapeutic perspectives
  5. The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
  6. IL-33 genetics and epigenetics in immune-related diseases
  7. COVID-19 pandemic: different roles for scientific publications and funding face to epidemiological data—an European, country-based perspective
  8. Processionary caterpillar reactions in Southern Italy forestry workers: description of three cases
  9. A spotlight on lime: a review about adverse reactions and clinical manifestations due to Citrus aurantiifolia
  10. IL-31, itch and hematological malignancies
  11. The potential role of cytokine storm pathway in the clinical course of viral respiratory pandemic
  12. Multiple myeloma cell-derived exosomes: Implications on tumorigenesis, diagnosis, prognosis and therapeutic strategies
  13. Nanomedicine for immunotherapy targeting hematological malignancies: Current approaches and perspective
  14. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
  15. Mental illness and amyloid: A scoping review of scientific evidence over the last 10 years (2011 to 2021)
  16. A machine learning application to predict early lung involvement in scleroderma: A feasibility evaluation
  17. Safety of medical cannabis in neuropathic chronic pain management
  18. Basophils and mast cells in COVID-19 pathogenesis
  19. Post-mastectomy pain: An updated overview on risk factors, predictors, and markers
  20. The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study
  21. Involvement of alarmins in the pathogenesis and progression of multiple myeloma
  22. Vitamin D deficiency, osteoporosis and effect on autoimmune diseases and hematopoiesis: A review
  23. Sharing the same perspective. Mental disorders and central serous chorioretinopathy: A systematic review of evidence from 2010 to 2020
  24. Involvement of micrornas as a response to phototherapy and photodynamic therapy: A literature review
  25. Role of vitamin d in the clinical course of nasal polyposis
  26. Therapies with antioxidant potential in psoriasis, vitiligo, and lichen planus
  27. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms
  28. Central serous chorioretinopathy and personality characteristics: A systematic review of scientific evidence over the last 10 years (2010 to 2020)
  29. Mindfulness-based interventions for physical and psychological wellbeing in cardiovascular diseases: A systematic review and meta-analysis
  30. Vitamin d and folate as predictors of mmse in alzheimer’s disease: A machine learning analysis
  31. Epigenetic effects of benzene in hematologic neoplasms: The altered gene expression
  32. Latex PPE-induced reactions during the COVID-19 pandemic: gender and previous allergies as distinctive predisposing factors among healthcare workers
  33. Management of patients at risk of anaphylaxis after covid 19 vaccination
  34. The role of skin and gut microbiome and epigenetic modifications in skin-autoimmune disorders
  35. Reviewing the significance of vitamin d substitution in monoclonal gammopathies
  36. Vitamin d and microbiota: Is there a link with allergies?
  37. New insights into yes-associated protein signaling pathways in hematological malignancies: Diagnostic and therapeutic challenges
  38. Bergamottin and 5-geranyloxy-7-methoxycoumarin cooperate in the cytotoxic effect of citrus bergamia (Bergamot) essential oil in human neuroblastoma sh-sy5y cell line
  39. Il-33 in mental disorders
  40. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm
  41. The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis
  42. Nickel sensitization influence on microbiota in allergic and non-allergic disorders: What’s up?
  43. Nutraceuticals against oxidative stress in autoimmune disorders
  44. IL-33/Vitamin D Crosstalk in Psoriasis-Associated Osteoporosis
  45. Alarmins, COVID-19 and comorbidities
  46. A flavonoid-rich extract of mandarin juice counteracts 6-ohda-induced oxidative stress in sh-sy5y cells and modulates parkinson-related genes
  47. Urticaria and coronavirus infection: A lesson from sars-cov-2 pandemic
  48. Pain biomarkers in cancer: An overview
  49. Oxidative stress as a key feature of autoimmune thyroiditis: An update
  50. Involvement of RAGE and oxidative stress in inflammatory and infectious skin diseases
  51. Microbiota and microRNAs in lung diseases: Mutual influence and role insights
  52. The impact of immunological checkpoint inhibitors and targeted therapy on chronic pruritus in cancer patients
  53. Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies
  54. The osteoporosis/microbiota linkage: The role of miRNA
  55. Synergic crosstalk between inflammation, oxidative stress, and genomic alterations in BCR-ABL-negative myeloproliferative neoplasm
  56. S100B in heart diseases
  57. Atopic dermatitis severity during exposure to air pollutants and weather changes with an Artificial Neural Network (ANN) analysis
  58. Involvement of miR-142 and miR-155 in non-infectious complications of CVID
  59. Tranexamic acid adverse reactions: A brief summary for internists and emergency doctors
  60. Role of alarmins in the pathogenesis of systemic sclerosis
  61. Rich at risk: Socio-economic drivers of COVID-19 pandemic spread
  62. Immunopathology of SARS-CoV-2 infection: Immune cells and mediators, prognostic factors, and immune-therapeutic implications
  63. Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges
  64. Detecting collagen molecules at picogram level through electric field-induced accumulation
  65. Anticancer activity of rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials
  66. Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology
  67. Oxidative stress and photodynamic therapy of skin cancers: Mechanisms, challenges and promising developments
  68. Jellyfish anaphylaxis: A wide spectrum of sensitization routes
  69. Omalizumab retreatment in patients with chronic spontaneous urticaria: A systematic review of published evidence
  70. Neuroprotective effect of bergamot juice in 6-OHDA-induced sh-sy5y cell death, an in vitro model of parkinson’s disease
  71. Interactions between the micrornas and microbiota in cancer development: Roles and therapeutic opportunities
  72. Oxidative stress and atopic dermatitis
  73. Oxidative stress involvement in urticaria
  74. Cannabinoids, blood–brain barrier, and brain disposition
  75. Alarmins in osteoporosis, RAGE, IL-1, and IL-33 pathways: A literature review
  76. Allergic reactions to genus Morus plants: A review
  77. Clinico-biological implications of modified levels of cytokines in chronic lymphocytic leukemia: A possible therapeutic role
  78. The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients
  79. Citrus fruits and their flavonoids in inflammatory bowel disease: an overview
  80. Vitamin deficiency as risk factor for SARS-CoV-2 infection: Correlation with susceptibility and prognosis
  81. Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients
  82. Il-33/il-31 axis in immune-mediated and allergic diseases
  83. MiR-21 upregulation increases IL-8 expression and tumorigenesis program in airway epithelial cells exposed to cigarette smoke
  84. Interleukin-33 serum levels in postmenopausal women with osteoporosis
  85. Commentary: Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
  86. The ST2/interleukin-33 axis in hematologic malignancies: The IL-33 paradox
  87. Formaldehyde exposure and acute myeloid leukemia: A review of the literature
  88. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications
  89. Oxidative stress involvement in psoriasis: a systematic review
  90. Effects of antagomiRs on different lung diseases in human, cellular, and animal models
  91. Citrus fruits and inflammaging: a systematic review
  92. Systemic nickel allergy syndrome: Tips and tricks on how to be suspected and treated
  93. Lymphocyte subsets and inflammatory cytokines of monoclonal gammopathy of undetermined significance and multiple myeloma
  94. Interleukin-33 involvement in nonsmall cell lung carcinomas: An update
  95. The Potential Role of MicroRNAs as Biomarkers in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
  96. Evaluation of the AGE/sRAGE axis in patients with multiple myeloma
  97. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto’s thyroiditis
  98. IL33/ST2 axis in diabetic kidney disease: A literature review
  99. PPI adverse drugs reactions: A retrospective study
  100. Possible roles of il-33 in the innate-Adaptive immune crosstalk of psoriasis pathogenesis
  101. MicroRNA cross-involvement in autism spectrum disorders and atopic dermatitis: A literature review
  102. Oxidative stress markers in patients with hereditary angioedema
  103. Do alarmins have a potential role in autism spectrum disorders pathogenesis and progression?
  104. The role of oxidative stress in the biology of melanoma: A systematic review
  105. Oral adverse reactions due to cinnamon-flavoured chewing gums consumption
  106. Drug induced Kounis syndrome: Does oxidative stress play a role?
  107. The involvement of osmolarity in the safety of contrast media
  108. IL-33/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients
  109. Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: A systematic review
  110. Involvement of miR-126 in autoimmune disorders
  111. Hymenoptera sting reactions in southern Italy forestry workers: Our experience compared to reported data
  112. Association between urticaria and nematode infections
  113. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience
  114. Clinical pharmacology of citrus aurantium and citrus sinensis for the treatment of anxiety
  115. Sodium oxybate therapy for alcohol withdrawal syndrome and keeping of alcohol abstinence
  116. IL-33/IL-31 axis: A potential inflammatory pathway
  117. A systematic review of the association between allergic asthma and autism
  118. MicroRNA profiling in asthma: Potential biomarkers and therapeutic targets
  119. Chlorinative stress in age-related diseases: A literature review
  120. Interleukin 31 and skin diseases: A systematic review
  121. Involvement of new oxidative stress markers in chronic spontaneous urticaria
  122. Exposure to Anisakis extracts can induce inflammation on in vitro cultured human colonic cells
  123. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products – part 4: Solidago virgaurea–Vitis vinifera
  124. Oxidation products are increased in patients affected by non-segmental generalized vitiligo
  125. How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma
  126. Anticancer potential of Citrus juices and their extracts: A systematic review of both preclinical and clinical studies
  127. A systematic review of overlapping microrna patterns in systemic sclerosis and idiopathic pulmonary fibrosis
  128. Interleukin 31 is involved in intrahepatic cholestasis of pregnancy
  129. The soft computing-based approach to investigate allergic diseases: A systematic review
  130. Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature
  131. Allergic diseases in the elderly: Biological characteristics and main immunological and non-immunological mechanisms
  132. Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review)
  133. Olfaction in autism spectrum disorders: A systematic review
  134. Immunosenescence in aging: Between immune cells depletion and cytokines up-regulation
  135. Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
  136. Association between HMGB1 and asthma: A literature review
  137. Involvement of microRNAs in skin disorders: A literature review
  138. Clinical Pharmacology of Citrus bergamia: A Systematic Review
  139. Different clinical allergological features of Taenia solium infestation
  140. Mucosal exfoliation as a selective reaction to etoricoxib
  141. Lethal anaphylactic reaction to intravenous gelatin in the course of surgery
  142. Chemopreventive agents and inhibitors of cancer hallmarks: May citrus offer new perspectives?
  143. Mastocytosis and systemic sclerosis: A clinical association
  144. Circulating advanced oxidation protein products as oxidative stress biomarkers and progression mediators in pathological conditions related to inflammation and immune dysregulation
  145. Neurodegenerative diseases: Might citrus flavonoids play a protective role?
  146. Anti-inflammatory activity of Citrus bergamia derivatives: Where do we stand?
  147. Unmet diagnostic needs in contact oral mucosal allergies
  148. Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review
  149. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo
  150. Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia
  151. Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis
  152. Reply to Fluegge: Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review
  153. Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity
  154. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - Part 3: Mentha × piperita - Solanum dulcamara
  155. Autism and social robotics: A systematic review
  156. NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells
  157. Relationship between lead exposure and mild cognitive impairment
  158. Association between urticaria and virus infections: A systematic review
  159. Fatal anaphylactic shock ceftriaxone-induced in a 4-year-old child
  160. Different co-sensitizations could determine different risk assessment in peach allergy? Evaluation of an anaphylactic biomarker in Pru p 3 positive patients
  161. Arterial stiffness as a predictor of recovery of left ventricular systolic function after acute myocardial infarction treated with primary percutaneous coronary intervention
  162. Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review
  163. Increased levels of interleukin 31 (IL-31) in osteoporosis
  164. Il-31 and il-33 circulating levels in allergic contact dermatitis
  165. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases
  166. Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell growth
  167. Catching allergy by a simple questionnaire
  168. Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo
  169. Review of clinical pharmacology of Aloe vera L. in the treatment of psoriasis
  170. Oxidative stress in benign prostatic hyperplasia: A systematic review
  171. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - Part 2: Echinacea purpurea-Lavandula angustifolia
  172. Oxidative stress markers are increased in patients with mastocytosis
  173. Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura
  174. Lymphoproliferative disease and cancer among patients with common variable immunodeficiency
  175. Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs
  176. Erythropoiesis-stimulating agents: Dose and mortality risk
  177. Association between HMGB1 and COPD: A systematic review
  178. Interleukin-10 involvement in exposure to low dose of benzene
  179. A quick bailout ongoing of cardiogenic shock and iatrogenic dissection of the left main coronary artery
  180. [Possible role of interleukin-31/33 axis in imatinib mesylate-associated skin toxicity, İmatinib mesilat ile İlişkili deri toksisitesinde İnterlökin-31/33 aksının olası rolü]
  181. Vitamin D deficiency in HIV infection: Not only a bone disorder
  182. Clinical pharmacology of melatonin in the treatment of tinnitus: A review
  183. Cutaneous adverse reactions to lenalidomide
  184. Oxidative stress markers in patients with hymenoptera venom allergy
  185. Pityriasis rosea of Gibert: Immunological aspects
  186. Different serum levels of interleukin-23 in patients affected by peripheral arterial disease
  187. Fatal multi-organ failure following anaphylactic shock induced by ceftriaxone
  188. Montelukast-induced adverse drug reactions: A review of case reports in the literature
  189. A survey of clinical features of allergic rhinitis in adults
  190. Rosmarinus officinalis L. as cause of contact dermatitis
  191. Allergy and risk of hematologic malignancies: Associations and mechanisms
  192. Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas
  193. Autism and lack of D3 vitamin: A systematic review
  194. Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells
  195. Cytokine network involvement in subjects exposed to benzene
  196. Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a
  197. Urticaria and bacterial infections
  198. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls
  199. 25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airways
  200. Cigarette smoke alters IL-33 expression and release in airway epithelial cells
  201. Adverse reaction after administration of progesterone
  202. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - Part 1: Achillea millefolium-Curcuma longa
  203. Systematic review of clinical trials assessing pharmacological properties of salvia species on memory, cognitive impairment and Alzheimer's disease
  204. Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis
  205. Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia
  206. Circulating levels of interleukin-22 in dialysis patients
  207. Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials
  208. IL-33/IL-31 axis: A new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity
  209. Fatal hypersensitivity reaction to an oral spray of flurbiprofen: A case report
  210. Chronic idiopathic urticaria and Graves' disease
  211. Oxidative stress in oncohematologic diseases: An update
  212. Attitudes and opinion about adverse drug events of women living in a city of South Italy
  213. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis
  214. Airborne contact dermatitis to drugs
  215. Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia
  216. Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
  217. Is IL-22 involved in celiac disease?
  218. Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis
  219. [The unusual association of graves' disease, chronic spontaneous urticaria, and premature ovarian failure: Report of a case and HLA haplotype characterization, A associação incomum entre doença de graves, urticária crônica idiopática e insufciência ovariana prematura: Relato de caso clínico e tipagem HLA]
  220. Systemic nickel allergy: Oral desensitization and possible role of cytokines interleukins 2 and 10
  221. Interleukin (IL)-22 serum level in hypersensitivity pneumonitis (HP) in a mushroom worker
  222. Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia
  223. Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia
  224. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions
  225. Drug-induced TINU syndrome and genetic characterization
  226. Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia
  227. Urticaria caused by dimenhydrinate
  228. Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients
  229. Healthy centenarians show high levels of circulating interleukin-22 (IL-22)
  230. Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene
  231. Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients
  232. Interleukin-23 serum levels in patients affected by peripheral arterial disease
  233. Anaphylaxis caused by helminths: review of the literature.
  234. Ultrarush venom immunotherapy and the lipoxin a 4 inflammation resolution pathway
  235. Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-Chronic lymphocytic leukemia
  236. Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients
  237. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia
  238. Allergic contact dermatitis: Immune system involvement and distinctive clinical cases
  239. Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: Preliminary data and future perspectives
  240. The adhesion molecule ICAM-1 is overexpressed in patients with hymenoptera venom allergy and decreases after ultrarush venom immunotherapy
  241. Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient
  242. Urticaria and thyroid autoimmunity
  243. Safety and reliability of the drug tolerance test: Our experience in 739 patients
  244. Fatal anaphylaxis in a 15-year-old boy with Down syndrome.
  245. Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization
  246. Sublingual immunotherapy in polysensitized patients: Effect on quality of life
  247. Hypersensitivity to tranexamic acid: A wide spectrum of adverse reactions
  248. Dermatomyositis and cutaneous metastases from breast cancer: Simultaneous development and parallel course
  249. Sublingual immunotherapy in children with allergic polysensitization
  250. Is interleukin-22 a possible indicator of chronic heart failure's progression?
  251. The role of dental series patch tests in oral mucosal diseases
  252. HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine
  253. Serum levels of carbonylated and nitrosylated proteins in mobbing victims with workplace adjustment disorders
  254. Fatal anaphylactic shock due to a dental impression material
  255. Protein carbonyl contents in cerebrospinal fluid and serum of patients affected by multiple sclerosis
  256. Serum levels of protein oxidation products in patients with nickel allergy
  257. Sublingual immunotherapy in polysensitized allergic patients with rhinitis and/or asthma: Allergist choices and treatment efficacy
  258. Increased serum levels of interleukin-22 in patients affected by pityriasis rosea
  259. Schnitzler syndrome: A new entity in allergological practice
  260. Bilateral cyclic cheek lesions related to premenstrual syndrome: A multifactorial pathogenesis?
  261. Protein contact dermatitis and allergic asthma caused by Anisakis simplex
  262. Fatal anaphylactic shock and Taenia Solium infestation: A possible link?
  263. Allergic response to a para-amino compound
  264. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDs
  265. Serum thyroid autoantibodies in patients with idiopathic either acute or chronic urticaria
  266. Increased serum levels of IL-22 in patients with nickel contact dermatitis
  267. Development of Hashimoto's thyroiditis after subacute thyroiditis: An unusual patient
  268. Chlamydophila psittaci seropositivity and serum levels of soluble intercellular adhesion molecule-1 in farmers
  269. Pomegranate-dependent exercise-induced anaphylaxis
  270. Characteristics of patients with allergic polysensitization: The polismail study
  271. Smoking, health and ageing
  272. Hypersensitivity to inhibitors of gastric secretion: Our experience and review of the literature
  273. Intermittent and persistent allergic rhinitis and association with asthma in children
  274. The importance of the patch test (as a preventive method) before an orthopaedic prosthesis implantation: A case report
  275. [Adverse drug reactions in geriatric age, Reazioni avverse a farmaci in età geriatrica]
  276. Fragrances as a cause of food allergy
  277. Cross-reactivity between Parietaria pollen and beet
  278. Allergic contact dermatitis due to Zantedeschia aethiopica
  279. Genetics of chronic obstructive pulmonary disease
  280. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea [27]
  281. Serum levels of sICAM-1 in subjects affected by systemic nickel allergy syndrome
  282. Liver and bile ducts involvement due to sarcoidosis
  283. Increased protein carbonyl groups in the serum of patients affected by thalassemia major
  284. Allergic contact angioedema to benzoyl peroxide
  285. Two cases of food-dependent exercise-induced anaphylaxis
  286. Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: Report of two cases
  287. Muscle damage induced by black cohosh (Cimicifuga racemosa)
  288. [Correlation of spirometry with blood levels of cytokines in patients with pulmonary sarcoidosis, Validità delle prove di funzionalità respiratoria in correlazione con la determinazione di alcune citochine in pazienti con sarcoidosi polmonare]
  289. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization
  290. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization
  291. Cerebral vasculitis in two patients affected by Hodgkin's lymphoma
  292. A case of contact urticaria due to adigraf, a PVC-made material
  293. Age-related modifications in circulating IL-15 levels in humans
  294. The almond milk: A new approach to the management of cow-milk allergy/intolerance in infants
  295. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels
  296. [Effects of premedication in subjects with previous adverse drug reaction submitted to general anaesthesia, Efficacia della premedicazione in soggetti con pregressa reazione avversa a farmaci sottoposti ad anestesia generale]
  297. Increased serum levels of CX3C-chemokine fractalkine in coeliac disease
  298. Modification of interleukin-15 serum levels in workers exposed to chemotherapeutic agents
  299. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by the inflammatory diseases allergic rhinitis and/or asthma
  300. Circulating levels of interleukin-18 in asbestos-exposed workers
  301. The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvement
  302. Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma
  303. Serum levels of malondialdehyde and 4-hydroxy-2,3-nonenal in patients affected by familial chronic nail candidiasis
  304. Vardenafil-induced generalized urticaria
  305. Montelukast-induced generalized urticaria
  306. [Safety of levofloxacin and clarithromycin in challenge-test for antibiotics: An experience, Sicurezza di impiego della levofloxacina e della claritromicina nei test di tolleranza per antibiotici: Esperienza personale]
  307. Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression
  308. Contact dermatitis from a fishing rod
  309. Lower platelet count in healthy centenarians correlates with dispersion of the QT interval
  310. Allergy to red chicory (Cichorium intybus var. sylvestre)
  311. Serum levels of interleukin-18 in splenectomized and nonsplenectomized thalassemic patients: Preliminary considerations
  312. Protein carbonyl group content in patients affected by familiar chronic nail candidiasis
  313. Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
  314. A gene for familial isolated chronic nail candidiasis maps to chromosome 11p12-q12.1
  315. Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity?
  316. Physical exercise increases urinary excretion of lipoxin A4 and related compounds
  317. [Effect of desloratadine on interleukin-18 release in patients affected by allergic contact dermatitis, Effetto di desloratadina sul rilascio di interleuchina-18 in una popolazione di pazienti affetti da dermatite allergica da contatto]
  318. Latex allergy and fruit cross-reaction in subjects who are nonatopic
  319. Specific immunotherapy effect on interleukin-18 and CD30 serum levels in monosensitized patients with rhinitis
  320. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
  321. Malondialdehyde in benign prostate hypertrophy: A useful marker?
  322. Candesartan cilexetil-induced severe hepatotoxicity
  323. Relationship between IL-18 and sICAM-1 serum levels in patients affected by coeliac disease: Preliminary considerations
  324. Serum levels of interleukin-18 in subjects affected by occupational allergic contact dermatitis [4]
  325. [Burning mouth syndrome: The role of contact hypersensitivity, La sindrome della bocca bruciante: Ruolo dell'ipersensibilità da contatto]
  326. Correlation between serum retinol and α-tocopherol levels in centenarians
  327. Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: Preliminary considerations
  328. An epidemiological survey of Cupressaceae pollenosis in Italy
  329. Involvement of interleukin-18 in patients on maintenance haemodialysis
  330. Cadmium concentration in maternal and cord blood and infant birth weight: A study on healthy non-smoking women
  331. In vitro effect of fluticasone propionate on interleukin 8 production by monocytes obtained from patients affected by moderate-severe allergic asthma
  332. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression
  333. In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes
  334. Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins
  335. Familial chronic nail candidiasis with ICAM-1 deficiency: A new form of chronic mucocutaneous candidiasis
  336. Influence of 5-fluorouracil and folinic acid on interleukin-18 production in colorectal cancer patients
  337. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study
  338. Nickel allergy, a model of food cellular hypersensitivity?
  339. Immediate reaction to clarithromycin
  340. Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: Preliminary considerations
  341. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma
  342. Allergy to gelatin
  343. Burning mouth syndrome due to cadmium in a denture wearer
  344. Aluminium allergy in a patient with occupational contact dermatitis
  345. Fluticasone propionate reduces serum interleukin-8 levels in asthmatic patients
  346. Evaluation of interleukin-18 production by in vitro differentiated monocytes from breast cancer patients
  347. In vitro interleukin-8 production by monocytes treated with lithium chloride from breast cancer patients
  348. Incidence of sensitivity to Anisakis simplex in a risk population of fishermen/fishmongers
  349. In vitro effect of lithium chloride on interleukin-15 production by monocytes from breast cancer patients
  350. Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both
  351. A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES)
  352. Effect of fluticasone propionate on interleukin-12 and interferon-γ production in patients affected by allergic bronchial asthma
  353. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients
  354. Urticaria from Trichomonas vaginalis infection
  355. Non invasive assessment of cardiac function in patients with bronchial asthma (BA) or chronic obstructive pulmonary disease (COPD)
  356. Urticaria in a tattooed patient
  357. Angioedema due to chironoida larvae used as fish food [10]
  358. Comparative study between fluticasone propionate and cetirizine in the treatment of allergic rhinitis
  359. Lodoxamide versus spaglumic acid: A comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by parietaria pollen
  360. [Ciprofloxacin in the treatment of exacerbations of chronic obstructive bronchopulmonary disease, La ciprofloxacina nel trattamento delle riacutizzazioni della broncopneumopatia cronica ostruttiva (BPCO)]
  361. Ethylene oxide allergy in dialysis patients
  362. Prevalence of Hymenoptera sensitivity in Italy
  363. New therapeutic approaches in atopic dermatitis
  364. The fate of specific immunotherapy
  365. Severe adverse reactions during specific subcutaneous immunotherapy
  366. Systemic contact dermatitis to copper-containing IUD
  367. [The role of dust mites in the determination of perpetual respiratory disease, RUOLO DEGLI ACARI DELLA POLVERE NEL DETERMINISMO DI PATOLOGIE RESPIRATORIE PERENNI]
 
 
 
 

    Curriculum

    CURRICULUM VITAE
    PROF. SEBASTIANO GANGEMI

    ORDINARY PROFESSOR MED / 09
    INTERNAL MEDICINE

    DIRECTOR OF THE SCHOOL OF SPECIALIZATION OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY
    DEPARTMENT OF CLINICAL AND EXPERIMENTAL MEDICINE
    UNIVERSITY OF MESSINA

    DIRECTOR OF THE U.O.S.D. OF ALLERGOLOGY AND CLINICAL IMMUNOLOGY
    DEPARTMENT OF MEDICAL SCIENCES
    A.O.U. POLICLINICO “G. MARTINO "OF MESSINA

    ACADEMIC CURRICULUM

    GRADUATION
    Prof. Sebastiano Gangemi, on 16/07/1992 obtained a degree in Medicine and Surgery at the University of Messina with a grade of 110/110 and academic honors.

    SPECIALIZATION
    On 21/10/1996 he obtained the Specialization Diploma in Allergology and Clinical Immunology at the Faculty of Medicine and Surgery of the University of Messina with a grade of 50/50 cum laude, discussing the thesis "Nickel and food".

    In the academic year 1995-96 he received the Lofarma prize for the best specialization thesis in Allergology and Clinical Immunology.

     On 13/10/1997 he obtained the Post-University Specialization Course in Risks and Pathology at Work at the Faculty of Medicine and Surgery of Messina with a grade of 50/50 and academic honors, discussing the thesis "Air pollution and respiratory allergies ".

    PH.D
    On 25/02/2002 he obtained the PhD in Experimental Medicine with the thesis "Role of cytokines in the pathogenesis of allergic bronchial asthma".

    UNIVERSITY RESEARCHER IN INTERNAL MEDICINE
    In 2001 he won the competition for University Researcher in Internal Medicine (scientific disciplinary sector MED09), and, with this qualification, he took up service on 25/06/2001 at the OU. of Allergology and Clinical Immunology of the Department of Human Pathology of the University Hospital of Messina, where he currently serves.

    COLLEGIO GIUNTA DEPARTMENT
    On 11/24/2004 he was elected among the members of the Board of the Human Pathology Department Council of the Faculty of Medicine and Surgery of the University of Messina.
    On 13/11/2013 he was elected among the members of the Board of the Department of Clinical and Experimental Medicine of the University of Messina.

    ASSOCIATE PROFESSOR IN INTERNAL MEDICINE
    In December 2005 he won the competition for Associate Professor in Internal Medicine (scientific disciplinary sector MED09) (DR 30/12/05), and, with this qualification, he took up service on 03/02/2006 at the U.O.C. of Allergology and Clinical Immunology of the Department of Human Pathology of the University Hospital of Messina,


    ORDINARY PROFESSOR IN INTERNAL MEDICINE
    Since December 2021 Ordinary Professor in Internal Medicine at the University of Messina.

    On 31/08/09, Associate Professor was confirmed by Rector's Decree.
    From 8 May 2006 to 31 December 2006 he was Head of the Allergy Clinic at the Division of Allergy and Clinical Immunology of the University of Messina.

    DIRECTOR OF THE SCHOOL OF SPECIALIZATION IN CLINICAL ALLERGOLOGY AND IMMUNOLOGY
    On 10 November 2006 he was appointed, by Rector's Decree, Director of the School of Specialization in Allergology and Clinical Immunology of the Faculty of Medicine and Surgery of the University of Messina, a position he still holds today.

    GUARANTOR UNIVERSITY OF MESSINA 2009-2011
    On 06 October 2009, by Rector's Decree, he was appointed to the Commission of the three guarantors of the University of Messina for a two-year period.

    MANAGEMENT OF OPERATING UNITS
    From 1 November 2008 to 29/06/09 he had the temporary role of Director of the U.O.C. of Allergology and Clinical Immunology of the University Hospital of Messina.
    With resolution of 23/06/09, from 29/06/09 until 31/12/2019 he held the management position of Director of the U.O.C. of Allergology and Clinical Immunology.
    From 01/01/2020 he has held the position of Director of U.O.S.D. following the transformation of the U.O.C. of Allergology and Clinical Immunology in a Simple Departmental Structure for adaptation of the Business Plan to the indications provided by the D.A. 22/2019 of the Regional Health Department (Sicily Region).
    In 2012 he obtained the Diploma of the Managerial Training Course for access to positions relating to the functions of Director of a Complex Structure.


    RESEARCH ACTIVITIES AT ANOTHER BODY
    From 01/04/2003 to 30/09/2003 he was on leave for research purposes at the Molecular Biology laboratory of Ce.S.I. (Center of Excellence on Aging), Department of Biomedical Sciences, of the G. D'Annunzio University of Chieti as part of a study on immunological changes in the course of aging

    From 01/11/2003 to 30/10/2004 he was again on leave for research purposes at the Molecular Biology laboratory of Ce.S.I. as part of a study on the mechanisms of the inflammatory response and its resolution.

    CNR - ASSOCIATION AND COORDINATION OF PROJECTS
    From 14 October 2009 to 31 December 2015 he obtained an association with the IBIM (Institute of Biomedicine and Molecular Immunology - CNR) of the CNR.
    From October 2015 for a year he was associated with the ISASI (Institute of Applied Sciences and Intelligent Systems) of the CNR (National Research Council).
    From 01 January 2020 IRIB association (Institute of Research and Innovation in the Biomedical field) of the CNR.

    INTERNATIONAL PUBLICATIONS AND PARAMETERS
    He is the author of 367 international papers in English in exstenso on journals with impact factor;
    has an H index of 41 and 6047 citations on Scopus and an H of 49 and 8516 citations on Google Scholar.
    Since 2018 he is part of the Top Italian Scientists (http://www.topitalianscientists.org).

    ORGANIZATION AND PARTICIPATION IN CONFERENCES
    He has participated, as a speaker, in over 130 congresses in Italy and abroad. Organizer of several national congresses of the SIAAIC and AIA.

    TEACHING DEGREE COURSES, SPECIALIZATION SCHOOLS AND RESEARCH DOCTORATES
    Currently he teaches at 2 Degree Courses of the University of Messina (Degree Course in Medicine and Surgery, Degree Course in Motor Sciences, Sport and Health), 1 PhD in Translational Molecular Medicine and Surgery, and in 3 Schools of Specialization.
    Since the 2001/2002 academic year he has been a lecturer at the Degree Course in Medicine and Surgery at the University of Messina, teaching in Allergology and Clinical Immunology.
    Since the 2015/2016 academic year he has been a lecturer at the Degree Course in Motor Sciences, Sport and Health at the University of Messina, teaching Principles of Medicine Applied to Motor Sciences I.
    In the 2004/2005 academic year he was a member of the Board of Professors of the Research Doctorate in "Aging: demography, biology and clinic", 20th cycle.
    From the 2010/2011 academic year to 2012/2013 he was a member of the Board of Professors of the Research Doctorate in "Clinical and translational research in the intensive therapy of cardio-renal syndrome and kidney transplantation".
    From Academic Year 2013/2014 to 2017/2018 member of the Board of Professors of the PhD in Clinical and Experimental Biomedical Sciences.
    From 12/03/2019 member of the Board of Professors of the PhD in Translational Molecular Medicine and Surgery.
    Since the 2001/2002 academic year he has been awarded the following teaching positions at the School of Specialization in Allergology and Clinical Immunology of the Faculty of Medicine and Surgery of the University of Messina:
    - Allergological and Immunological Diagnostics "in vivo" I (I year)
    - Allergological and Immunological Diagnostics "in vivo" III (IV year)
    From the 2004/2005 academic year he had the following positions at the School of Specialization in Allergology and Clinical Immunology of the Faculty of Medicine and Surgery of the University of Messina:
    - Methodology and Allergological Semeiotics I (1st year)
    - Allergological and immunological diagnostics "in vivo" II (IV year)
    From the 2004/2005 academic year to today he has been awarded the following teaching position at the School of Specialization in Hospital Pharmacy of the Faculty of Pharmacy of the University of Messina:
    - Immunology
    From the 2004/2005 academic year to 2010/2011 he was awarded the following teaching position at the School of Specialization in Pediatric Genetics of the Faculty of Medicine and Surgery of the University of Messina:
    - Immunology
    Since the 2001/2002 academic year, he has been a member of the lecturers of the "Integrated Course of Allergology and Clinical Immunology and Rheumatology" at the Degree Course in Medicine and Surgery of the University of Messina
    From the 2005/2006 academic year to 2017/2018 he was awarded the following teaching position at the School of Specialization in Gynecology and Obstetrics of the Faculty of Medicine and Surgery of the University of Messina:
          - Immunology of pregnancy
     From the 2008/209 academic year to 2015/2016 he was awarded the following teaching position at the School of Specialization in Rheumatology of the Faculty of Medicine and Surgery of the University of Messina:
    - Clinical immunology
    From the 2009/2010 academic year to 2014/2015 he was awarded the following teaching position at the School of Specialization in Sports Medicine of the Faculty of Medicine and Surgery of the University of Messina:
          - Clinical immunology
    From the 2012/2013 academic year to date he has been awarded the following teaching position at the School of Specialization in Pediatrics of the Faculty of Medicine and Surgery of the University of Messina:
    - Immunology

    COORDINATION OF INTEGRATED COURSES
    From the academic year 2019/20 Coordinator of the Integrated Course in RHEUMATOLOGY, ALLERGOLOGY AND CLINICAL IMMUNOLOGY of the Degree Course in Medicine and Surgery;
    From the academic year 2019/20 Coordinator of the Integrated Course in PRINCIPLES OF MEDICINE APPLIED TO MOTOR SCIENCES I of the Degree Course in Motor Sciences, Sport and Health.
    HEAD OF THE ERASMUS PROGRAM
    From 24 June 2019, he was appointed "Head of International Mobility of the Degree Course in Motor Sciences, Sport and Health L 22" starting from the 2019/20 academic year. In this capacity, he also plays the role of “Responsible person at the Sending / Receiving Institution” in the ERASMUS + Program that the Degree Program has activated with various European University Offices.

    NATIONAL DIRECTIVE COUNCILS
    From October 2000 to November 2002 he was a member of the National Executive Council of the AIA (Italian Society of Aerobiology)
    Subsequently, from June 2003 to April 2006, he again held the position of member of the AIA National Board of Directors
    From April 2006 to May 2009, he again held the position of member of the AIA National Board of Directors for the three-year period 2006/2009
    In October 2008, he was elected a member of the National Board of SIAIC for the three-year period 2008/2011.
    Subsequently in May 2011 he was re-elected to the National Executive Council of the SIAIC for the three-year period 2011/2014.
    Since 2019 Member of the Executive Board, with the position of Treasurer, of the Italian Society of Allergy, Asthma and Clinical Immunology.

    EDITORIAL BOARD
    Since January 2017 he is Section Editor of Clinical Molecular Allergy
    Since November 2019 he is Section Editor of the Current Molecular Medicine journal
    Since 2020 he has been a member of the International Board of the Allergy and Asthma Proceedings magazine

    AWARDS
    In the academic year 1995/96 he won the LOFARMA prize for the best Specialization Thesis in Allergy and Clinical Immunology entitled "Nickel and food".
    In 2016, winner of the "ALATA SOLERTIA" XXXIII Edition awarded by the "Giorgio La Pira" New Presence Movement.
    COLLABORATIONS WITH OTHER NATIONAL AND INTERNATIONAL RESEARCH BODIES

    INTERNATIONAL RESEARCH INSTITUTIONS:


    - University of Colorado Health Sciences Center - Department of Medicine, Division of Infectious Diseases - Denver - Colorado - USA

    - Weizmann Institute of Science - Department of Molecular Genetics - Rehovot - Israel

    NATIONAL RESEARCH INSTITUTIONS:

    - Ce.S.I. (Center of Excellence on Aging) - Department of Biomedical Sciences - Molecular Medicine Laboratory - University "G. D'Annunzio "- Chieti
    - I.N.R.C.A. (Italian National Research Center on Aging) - Ancona
    - IRCCS-CSS San Giovanni Rotondo, CSS Mendel - Rome
    - IBIM (Institute of Biomedicine and Molecular Immunology) of the CNR (National Research Council).
    - Institute of Clinical Physiology IFC, Messina Unit, National Research Council (CNR)
    - "Stella Maris" Foundation
    - Institute of Applied Sciences and Intelligent Systems (ISASI), of the CNR (National Research Council).
    - IRIB - CNR (Institute for Research and Innovation in the Biomedical Field), of the CNR (National Research Council).
    List of publications:
     
    1. Hmgb-1 in psoriasis
    2. Autism spectrum disorders and atopic dermatitis: a new perspective from country-based prevalence data
    3. Current take on systemic sclerosis patients’ vaccination recommendations
    4. Role of epithelium-derived cytokines in atopic dermatitis and psoriasis: Evidence and therapeutic perspectives
    5. The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID-19
    6. IL-33 genetics and epigenetics in immune-related diseases
    7. COVID-19 pandemic: different roles for scientific publications and funding face to epidemiological data—an European, country-based perspective
    8. Processionary caterpillar reactions in Southern Italy forestry workers: description of three cases
    9. A spotlight on lime: a review about adverse reactions and clinical manifestations due to Citrus aurantiifolia
    10. IL-31, itch and hematological malignancies
    11. The potential role of cytokine storm pathway in the clinical course of viral respiratory pandemic
    12. Multiple myeloma cell-derived exosomes: Implications on tumorigenesis, diagnosis, prognosis and therapeutic strategies
    13. Nanomedicine for immunotherapy targeting hematological malignancies: Current approaches and perspective
    14. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
    15. Mental illness and amyloid: A scoping review of scientific evidence over the last 10 years (2011 to 2021)
    16. A machine learning application to predict early lung involvement in scleroderma: A feasibility evaluation
    17. Safety of medical cannabis in neuropathic chronic pain management
    18. Basophils and mast cells in COVID-19 pathogenesis
    19. Post-mastectomy pain: An updated overview on risk factors, predictors, and markers
    20. The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study
    21. Involvement of alarmins in the pathogenesis and progression of multiple myeloma
    22. Vitamin D deficiency, osteoporosis and effect on autoimmune diseases and hematopoiesis: A review
    23. Sharing the same perspective. Mental disorders and central serous chorioretinopathy: A systematic review of evidence from 2010 to 2020
    24. Involvement of micrornas as a response to phototherapy and photodynamic therapy: A literature review
    25. Role of vitamin d in the clinical course of nasal polyposis
    26. Therapies with antioxidant potential in psoriasis, vitiligo, and lichen planus
    27. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms
    28. Central serous chorioretinopathy and personality characteristics: A systematic review of scientific evidence over the last 10 years (2010 to 2020)
    29. Mindfulness-based interventions for physical and psychological wellbeing in cardiovascular diseases: A systematic review and meta-analysis
    30. Vitamin d and folate as predictors of mmse in alzheimer’s disease: A machine learning analysis
    31. Epigenetic effects of benzene in hematologic neoplasms: The altered gene expression
    32. Latex PPE-induced reactions during the COVID-19 pandemic: gender and previous allergies as distinctive predisposing factors among healthcare workers
    33. Management of patients at risk of anaphylaxis after covid 19 vaccination
    34. The role of skin and gut microbiome and epigenetic modifications in skin-autoimmune disorders
    35. Reviewing the significance of vitamin d substitution in monoclonal gammopathies
    36. Vitamin d and microbiota: Is there a link with allergies?
    37. New insights into yes-associated protein signaling pathways in hematological malignancies: Diagnostic and therapeutic challenges
    38. Bergamottin and 5-geranyloxy-7-methoxycoumarin cooperate in the cytotoxic effect of citrus bergamia (Bergamot) essential oil in human neuroblastoma sh-sy5y cell line
    39. Il-33 in mental disorders
    40. AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm
    41. The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis
    42. Nickel sensitization influence on microbiota in allergic and non-allergic disorders: What’s up?
    43. Nutraceuticals against oxidative stress in autoimmune disorders
    44. IL-33/Vitamin D Crosstalk in Psoriasis-Associated Osteoporosis
    45. Alarmins, COVID-19 and comorbidities
    46. A flavonoid-rich extract of mandarin juice counteracts 6-ohda-induced oxidative stress in sh-sy5y cells and modulates parkinson-related genes
    47. Urticaria and coronavirus infection: A lesson from sars-cov-2 pandemic
    48. Pain biomarkers in cancer: An overview
    49. Oxidative stress as a key feature of autoimmune thyroiditis: An update
    50. Involvement of RAGE and oxidative stress in inflammatory and infectious skin diseases
    51. Microbiota and microRNAs in lung diseases: Mutual influence and role insights
    52. The impact of immunological checkpoint inhibitors and targeted therapy on chronic pruritus in cancer patients
    53. Antiproliferative effects of st. John’s wort, its derivatives, and other hypericum species in hematologic malignancies
    54. The osteoporosis/microbiota linkage: The role of miRNA
    55. Synergic crosstalk between inflammation, oxidative stress, and genomic alterations in BCR-ABL-negative myeloproliferative neoplasm
    56. S100B in heart diseases
    57. Atopic dermatitis severity during exposure to air pollutants and weather changes with an Artificial Neural Network (ANN) analysis
    58. Involvement of miR-142 and miR-155 in non-infectious complications of CVID
    59. Tranexamic acid adverse reactions: A brief summary for internists and emergency doctors
    60. Role of alarmins in the pathogenesis of systemic sclerosis
    61. Rich at risk: Socio-economic drivers of COVID-19 pandemic spread
    62. Immunopathology of SARS-CoV-2 infection: Immune cells and mediators, prognostic factors, and immune-therapeutic implications
    63. Cancer and sars-cov-2 infection: Diagnostic and therapeutic challenges
    64. Detecting collagen molecules at picogram level through electric field-induced accumulation
    65. Anticancer activity of rosmarinus officinalis L.: Mechanisms of action and therapeutic potentials
    66. Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology
    67. Oxidative stress and photodynamic therapy of skin cancers: Mechanisms, challenges and promising developments
    68. Jellyfish anaphylaxis: A wide spectrum of sensitization routes
    69. Omalizumab retreatment in patients with chronic spontaneous urticaria: A systematic review of published evidence
    70. Neuroprotective effect of bergamot juice in 6-OHDA-induced sh-sy5y cell death, an in vitro model of parkinson’s disease
    71. Interactions between the micrornas and microbiota in cancer development: Roles and therapeutic opportunities
    72. Oxidative stress and atopic dermatitis
    73. Oxidative stress involvement in urticaria
    74. Cannabinoids, blood–brain barrier, and brain disposition
    75. Alarmins in osteoporosis, RAGE, IL-1, and IL-33 pathways: A literature review
    76. Allergic reactions to genus Morus plants: A review
    77. Clinico-biological implications of modified levels of cytokines in chronic lymphocytic leukemia: A possible therapeutic role
    78. The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients
    79. Citrus fruits and their flavonoids in inflammatory bowel disease: an overview
    80. Vitamin deficiency as risk factor for SARS-CoV-2 infection: Correlation with susceptibility and prognosis
    81. Changes in serum interleukin-8 and sRAGE levels in multiple myeloma patients
    82. Il-33/il-31 axis in immune-mediated and allergic diseases
    83. MiR-21 upregulation increases IL-8 expression and tumorigenesis program in airway epithelial cells exposed to cigarette smoke
    84. Interleukin-33 serum levels in postmenopausal women with osteoporosis
    85. Commentary: Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
    86. The ST2/interleukin-33 axis in hematologic malignancies: The IL-33 paradox
    87. Formaldehyde exposure and acute myeloid leukemia: A review of the literature
    88. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications
    89. Oxidative stress involvement in psoriasis: a systematic review
    90. Effects of antagomiRs on different lung diseases in human, cellular, and animal models
    91. Citrus fruits and inflammaging: a systematic review
    92. Systemic nickel allergy syndrome: Tips and tricks on how to be suspected and treated
    93. Lymphocyte subsets and inflammatory cytokines of monoclonal gammopathy of undetermined significance and multiple myeloma
    94. Interleukin-33 involvement in nonsmall cell lung carcinomas: An update
    95. The Potential Role of MicroRNAs as Biomarkers in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
    96. Evaluation of the AGE/sRAGE axis in patients with multiple myeloma
    97. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto’s thyroiditis
    98. IL33/ST2 axis in diabetic kidney disease: A literature review
    99. PPI adverse drugs reactions: A retrospective study
    100. Possible roles of il-33 in the innate-Adaptive immune crosstalk of psoriasis pathogenesis
    101. MicroRNA cross-involvement in autism spectrum disorders and atopic dermatitis: A literature review
    102. Oxidative stress markers in patients with hereditary angioedema
    103. Do alarmins have a potential role in autism spectrum disorders pathogenesis and progression?
    104. The role of oxidative stress in the biology of melanoma: A systematic review
    105. Oral adverse reactions due to cinnamon-flavoured chewing gums consumption
    106. Drug induced Kounis syndrome: Does oxidative stress play a role?
    107. The involvement of osmolarity in the safety of contrast media
    108. IL-33/s-ST2 ratio, systemic symptoms, and basophil activation in Pru p 3-sensitized allergic patients
    109. Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: A systematic review
    110. Involvement of miR-126 in autoimmune disorders
    111. Hymenoptera sting reactions in southern Italy forestry workers: Our experience compared to reported data
    112. Association between urticaria and nematode infections
    113. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience
    114. Clinical pharmacology of citrus aurantium and citrus sinensis for the treatment of anxiety
    115. Sodium oxybate therapy for alcohol withdrawal syndrome and keeping of alcohol abstinence
    116. IL-33/IL-31 axis: A potential inflammatory pathway
    117. A systematic review of the association between allergic asthma and autism
    118. MicroRNA profiling in asthma: Potential biomarkers and therapeutic targets
    119. Chlorinative stress in age-related diseases: A literature review
    120. Interleukin 31 and skin diseases: A systematic review
    121. Involvement of new oxidative stress markers in chronic spontaneous urticaria
    122. Exposure to Anisakis extracts can induce inflammation on in vitro cultured human colonic cells
    123. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products – part 4: Solidago virgaurea–Vitis vinifera
    124. Oxidation products are increased in patients affected by non-segmental generalized vitiligo
    125. How gene polymorphisms can influence clinical response and toxicity following R-CHOP therapy in patients with diffuse large B cell lymphoma
    126. Anticancer potential of Citrus juices and their extracts: A systematic review of both preclinical and clinical studies
    127. A systematic review of overlapping microrna patterns in systemic sclerosis and idiopathic pulmonary fibrosis
    128. Interleukin 31 is involved in intrahepatic cholestasis of pregnancy
    129. The soft computing-based approach to investigate allergic diseases: A systematic review
    130. Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature
    131. Allergic diseases in the elderly: Biological characteristics and main immunological and non-immunological mechanisms
    132. Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer (Review)
    133. Olfaction in autism spectrum disorders: A systematic review
    134. Immunosenescence in aging: Between immune cells depletion and cytokines up-regulation
    135. Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
    136. Association between HMGB1 and asthma: A literature review
    137. Involvement of microRNAs in skin disorders: A literature review
    138. Clinical Pharmacology of Citrus bergamia: A Systematic Review
    139. Different clinical allergological features of Taenia solium infestation
    140. Mucosal exfoliation as a selective reaction to etoricoxib
    141. Lethal anaphylactic reaction to intravenous gelatin in the course of surgery
    142. Chemopreventive agents and inhibitors of cancer hallmarks: May citrus offer new perspectives?
    143. Mastocytosis and systemic sclerosis: A clinical association
    144. Circulating advanced oxidation protein products as oxidative stress biomarkers and progression mediators in pathological conditions related to inflammation and immune dysregulation
    145. Neurodegenerative diseases: Might citrus flavonoids play a protective role?
    146. Anti-inflammatory activity of Citrus bergamia derivatives: Where do we stand?
    147. Unmet diagnostic needs in contact oral mucosal allergies
    148. Pathophysiological mechanism and therapeutic role of S100 proteins in cardiac failure: a systematic review
    149. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo
    150. Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia
    151. Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis
    152. Reply to Fluegge: Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review
    153. Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity
    154. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - Part 3: Mentha × piperita - Solanum dulcamara
    155. Autism and social robotics: A systematic review
    156. NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells
    157. Relationship between lead exposure and mild cognitive impairment
    158. Association between urticaria and virus infections: A systematic review
    159. Fatal anaphylactic shock ceftriaxone-induced in a 4-year-old child
    160. Different co-sensitizations could determine different risk assessment in peach allergy? Evaluation of an anaphylactic biomarker in Pru p 3 positive patients
    161. Arterial stiffness as a predictor of recovery of left ventricular systolic function after acute myocardial infarction treated with primary percutaneous coronary intervention
    162. Association Between Atopic Dermatitis and Autism Spectrum Disorders: A Systematic Review
    163. Increased levels of interleukin 31 (IL-31) in osteoporosis
    164. Il-31 and il-33 circulating levels in allergic contact dermatitis
    165. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases
    166. Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell growth
    167. Catching allergy by a simple questionnaire
    168. Increased serum levels of interleukin-23 circulating in patients with non-segmental generalized vitiligo
    169. Review of clinical pharmacology of Aloe vera L. in the treatment of psoriasis
    170. Oxidative stress in benign prostatic hyperplasia: A systematic review
    171. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - Part 2: Echinacea purpurea-Lavandula angustifolia
    172. Oxidative stress markers are increased in patients with mastocytosis
    173. Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura
    174. Lymphoproliferative disease and cancer among patients with common variable immunodeficiency
    175. Challenge test to bisphosphonates in patients with hypersensitivity reactions to drugs
    176. Erythropoiesis-stimulating agents: Dose and mortality risk
    177. Association between HMGB1 and COPD: A systematic review
    178. Interleukin-10 involvement in exposure to low dose of benzene
    179. A quick bailout ongoing of cardiogenic shock and iatrogenic dissection of the left main coronary artery
    180. [Possible role of interleukin-31/33 axis in imatinib mesylate-associated skin toxicity, İmatinib mesilat ile İlişkili deri toksisitesinde İnterlökin-31/33 aksının olası rolü]
    181. Vitamin D deficiency in HIV infection: Not only a bone disorder
    182. Clinical pharmacology of melatonin in the treatment of tinnitus: A review
    183. Cutaneous adverse reactions to lenalidomide
    184. Oxidative stress markers in patients with hymenoptera venom allergy
    185. Pityriasis rosea of Gibert: Immunological aspects
    186. Different serum levels of interleukin-23 in patients affected by peripheral arterial disease
    187. Fatal multi-organ failure following anaphylactic shock induced by ceftriaxone
    188. Montelukast-induced adverse drug reactions: A review of case reports in the literature
    189. A survey of clinical features of allergic rhinitis in adults
    190. Rosmarinus officinalis L. as cause of contact dermatitis
    191. Allergy and risk of hematologic malignancies: Associations and mechanisms
    192. Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas
    193. Autism and lack of D3 vitamin: A systematic review
    194. Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells
    195. Cytokine network involvement in subjects exposed to benzene
    196. Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a
    197. Urticaria and bacterial infections
    198. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls
    199. 25-Hydroxyvitamin D, IL-31, and IL-33 in children with allergic disease of the airways
    200. Cigarette smoke alters IL-33 expression and release in airway epithelial cells
    201. Adverse reaction after administration of progesterone
    202. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - Part 1: Achillea millefolium-Curcuma longa
    203. Systematic review of clinical trials assessing pharmacological properties of salvia species on memory, cognitive impairment and Alzheimer's disease
    204. Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis
    205. Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia
    206. Circulating levels of interleukin-22 in dialysis patients
    207. Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials
    208. IL-33/IL-31 axis: A new pathological mechanisms for EGFR tyrosine kinase inhibitors-associated skin toxicity
    209. Fatal hypersensitivity reaction to an oral spray of flurbiprofen: A case report
    210. Chronic idiopathic urticaria and Graves' disease
    211. Oxidative stress in oncohematologic diseases: An update
    212. Attitudes and opinion about adverse drug events of women living in a city of South Italy
    213. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis
    214. Airborne contact dermatitis to drugs
    215. Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia
    216. Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
    217. Is IL-22 involved in celiac disease?
    218. Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis
    219. [The unusual association of graves' disease, chronic spontaneous urticaria, and premature ovarian failure: Report of a case and HLA haplotype characterization, A associação incomum entre doença de graves, urticária crônica idiopática e insufciência ovariana prematura: Relato de caso clínico e tipagem HLA]
    220. Systemic nickel allergy: Oral desensitization and possible role of cytokines interleukins 2 and 10
    221. Interleukin (IL)-22 serum level in hypersensitivity pneumonitis (HP) in a mushroom worker
    222. Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia
    223. Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia
    224. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions
    225. Drug-induced TINU syndrome and genetic characterization
    226. Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia
    227. Urticaria caused by dimenhydrinate
    228. Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients
    229. Healthy centenarians show high levels of circulating interleukin-22 (IL-22)
    230. Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene
    231. Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients
    232. Interleukin-23 serum levels in patients affected by peripheral arterial disease
    233. Anaphylaxis caused by helminths: review of the literature.
    234. Ultrarush venom immunotherapy and the lipoxin a 4 inflammation resolution pathway
    235. Relationship between advanced oxidation protein products, advanced glycation end products, and S-nitrosylated proteins with biological risk and MDR-1 polymorphisms in patients affected by B-Chronic lymphocytic leukemia
    236. Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients
    237. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia
    238. Allergic contact dermatitis: Immune system involvement and distinctive clinical cases
    239. Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: Preliminary data and future perspectives
    240. The adhesion molecule ICAM-1 is overexpressed in patients with hymenoptera venom allergy and decreases after ultrarush venom immunotherapy
    241. Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient
    242. Urticaria and thyroid autoimmunity
    243. Safety and reliability of the drug tolerance test: Our experience in 739 patients
    244. Fatal anaphylaxis in a 15-year-old boy with Down syndrome.
    245. Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization
    246. Sublingual immunotherapy in polysensitized patients: Effect on quality of life
    247. Hypersensitivity to tranexamic acid: A wide spectrum of adverse reactions
    248. Dermatomyositis and cutaneous metastases from breast cancer: Simultaneous development and parallel course
    249. Sublingual immunotherapy in children with allergic polysensitization
    250. Is interleukin-22 a possible indicator of chronic heart failure's progression?
    251. The role of dental series patch tests in oral mucosal diseases
    252. HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine
    253. Serum levels of carbonylated and nitrosylated proteins in mobbing victims with workplace adjustment disorders
    254. Fatal anaphylactic shock due to a dental impression material
    255. Protein carbonyl contents in cerebrospinal fluid and serum of patients affected by multiple sclerosis
    256. Serum levels of protein oxidation products in patients with nickel allergy
    257. Sublingual immunotherapy in polysensitized allergic patients with rhinitis and/or asthma: Allergist choices and treatment efficacy
    258. Increased serum levels of interleukin-22 in patients affected by pityriasis rosea
    259. Schnitzler syndrome: A new entity in allergological practice
    260. Bilateral cyclic cheek lesions related to premenstrual syndrome: A multifactorial pathogenesis?
    261. Protein contact dermatitis and allergic asthma caused by Anisakis simplex
    262. Fatal anaphylactic shock and Taenia Solium infestation: A possible link?
    263. Allergic response to a para-amino compound
    264. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDs
    265. Serum thyroid autoantibodies in patients with idiopathic either acute or chronic urticaria
    266. Increased serum levels of IL-22 in patients with nickel contact dermatitis
    267. Development of Hashimoto's thyroiditis after subacute thyroiditis: An unusual patient
    268. Chlamydophila psittaci seropositivity and serum levels of soluble intercellular adhesion molecule-1 in farmers
    269. Pomegranate-dependent exercise-induced anaphylaxis
    270. Characteristics of patients with allergic polysensitization: The polismail study
    271. Smoking, health and ageing
    272. Hypersensitivity to inhibitors of gastric secretion: Our experience and review of the literature
    273. Intermittent and persistent allergic rhinitis and association with asthma in children
    274. The importance of the patch test (as a preventive method) before an orthopaedic prosthesis implantation: A case report
    275. [Adverse drug reactions in geriatric age, Reazioni avverse a farmaci in età geriatrica]
    276. Fragrances as a cause of food allergy
    277. Cross-reactivity between Parietaria pollen and beet
    278. Allergic contact dermatitis due to Zantedeschia aethiopica
    279. Genetics of chronic obstructive pulmonary disease
    280. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea [27]
    281. Serum levels of sICAM-1 in subjects affected by systemic nickel allergy syndrome
    282. Liver and bile ducts involvement due to sarcoidosis
    283. Increased protein carbonyl groups in the serum of patients affected by thalassemia major
    284. Allergic contact angioedema to benzoyl peroxide
    285. Two cases of food-dependent exercise-induced anaphylaxis
    286. Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: Report of two cases
    287. Muscle damage induced by black cohosh (Cimicifuga racemosa)
    288. [Correlation of spirometry with blood levels of cytokines in patients with pulmonary sarcoidosis, Validità delle prove di funzionalità respiratoria in correlazione con la determinazione di alcune citochine in pazienti con sarcoidosi polmonare]
    289. 'In vivo' time course of plasma myeloperoxidase levels after granulocyte colony-stimulating factor-induced stem cell mobilization
    290. Modification of the content of plasma protein carbonyl groups in donors after granulocyte colony stimulating factor-induced stem cell mobilization
    291. Cerebral vasculitis in two patients affected by Hodgkin's lymphoma
    292. A case of contact urticaria due to adigraf, a PVC-made material
    293. Age-related modifications in circulating IL-15 levels in humans
    294. The almond milk: A new approach to the management of cow-milk allergy/intolerance in infants
    295. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels
    296. [Effects of premedication in subjects with previous adverse drug reaction submitted to general anaesthesia, Efficacia della premedicazione in soggetti con pregressa reazione avversa a farmaci sottoposti ad anestesia generale]
    297. Increased serum levels of CX3C-chemokine fractalkine in coeliac disease
    298. Modification of interleukin-15 serum levels in workers exposed to chemotherapeutic agents
    299. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by the inflammatory diseases allergic rhinitis and/or asthma
    300. Circulating levels of interleukin-18 in asbestos-exposed workers
    301. The CX3C chemokine fractalkine (CX3CL1) is detectable in serum of B cell chronic lymphocytic leukemia patients with lymph node involvement
    302. Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma
    303. Serum levels of malondialdehyde and 4-hydroxy-2,3-nonenal in patients affected by familial chronic nail candidiasis
    304. Vardenafil-induced generalized urticaria
    305. Montelukast-induced generalized urticaria
    306. [Safety of levofloxacin and clarithromycin in challenge-test for antibiotics: An experience, Sicurezza di impiego della levofloxacina e della claritromicina nei test di tolleranza per antibiotici: Esperienza personale]
    307. Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression
    308. Contact dermatitis from a fishing rod
    309. Lower platelet count in healthy centenarians correlates with dispersion of the QT interval
    310. Allergy to red chicory (Cichorium intybus var. sylvestre)
    311. Serum levels of interleukin-18 in splenectomized and nonsplenectomized thalassemic patients: Preliminary considerations
    312. Protein carbonyl group content in patients affected by familiar chronic nail candidiasis
    313. Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
    314. A gene for familial isolated chronic nail candidiasis maps to chromosome 11p12-q12.1
    315. Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: Another paradox of longevity?
    316. Physical exercise increases urinary excretion of lipoxin A4 and related compounds
    317. [Effect of desloratadine on interleukin-18 release in patients affected by allergic contact dermatitis, Effetto di desloratadina sul rilascio di interleuchina-18 in una popolazione di pazienti affetti da dermatite allergica da contatto]
    318. Latex allergy and fruit cross-reaction in subjects who are nonatopic
    319. Specific immunotherapy effect on interleukin-18 and CD30 serum levels in monosensitized patients with rhinitis
    320. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
    321. Malondialdehyde in benign prostate hypertrophy: A useful marker?
    322. Candesartan cilexetil-induced severe hepatotoxicity
    323. Relationship between IL-18 and sICAM-1 serum levels in patients affected by coeliac disease: Preliminary considerations
    324. Serum levels of interleukin-18 in subjects affected by occupational allergic contact dermatitis [4]
    325. [Burning mouth syndrome: The role of contact hypersensitivity, La sindrome della bocca bruciante: Ruolo dell'ipersensibilità da contatto]
    326. Correlation between serum retinol and α-tocopherol levels in centenarians
    327. Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: Preliminary considerations
    328. An epidemiological survey of Cupressaceae pollenosis in Italy
    329. Involvement of interleukin-18 in patients on maintenance haemodialysis
    330. Cadmium concentration in maternal and cord blood and infant birth weight: A study on healthy non-smoking women
    331. In vitro effect of fluticasone propionate on interleukin 8 production by monocytes obtained from patients affected by moderate-severe allergic asthma
    332. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression
    333. In vitro effects of fluticasone propionate on IL-13 production by mitogen-stimulated lymphocytes
    334. Urinary excretion of lipoxin A4 and related compounds: Development of new extraction techniques for lipoxins
    335. Familial chronic nail candidiasis with ICAM-1 deficiency: A new form of chronic mucocutaneous candidiasis
    336. Influence of 5-fluorouracil and folinic acid on interleukin-18 production in colorectal cancer patients
    337. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study
    338. Nickel allergy, a model of food cellular hypersensitivity?
    339. Immediate reaction to clarithromycin
    340. Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: Preliminary considerations
    341. Effect of fluticasone propionate on soluble CD30 release in patients with severe allergic asthma
    342. Allergy to gelatin
    343. Burning mouth syndrome due to cadmium in a denture wearer
    344. Aluminium allergy in a patient with occupational contact dermatitis
    345. Fluticasone propionate reduces serum interleukin-8 levels in asthmatic patients
    346. Evaluation of interleukin-18 production by in vitro differentiated monocytes from breast cancer patients
    347. In vitro interleukin-8 production by monocytes treated with lithium chloride from breast cancer patients
    348. Incidence of sensitivity to Anisakis simplex in a risk population of fishermen/fishmongers
    349. In vitro effect of lithium chloride on interleukin-15 production by monocytes from breast cancer patients
    350. Sublingual immunotherapy: A double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both
    351. A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES)
    352. Effect of fluticasone propionate on interleukin-12 and interferon-γ production in patients affected by allergic bronchial asthma
    353. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients
    354. Urticaria from Trichomonas vaginalis infection
    355. Non invasive assessment of cardiac function in patients with bronchial asthma (BA) or chronic obstructive pulmonary disease (COPD)
    356. Urticaria in a tattooed patient
    357. Angioedema due to chironoida larvae used as fish food [10]
    358. Comparative study between fluticasone propionate and cetirizine in the treatment of allergic rhinitis
    359. Lodoxamide versus spaglumic acid: A comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by parietaria pollen
    360. [Ciprofloxacin in the treatment of exacerbations of chronic obstructive bronchopulmonary disease, La ciprofloxacina nel trattamento delle riacutizzazioni della broncopneumopatia cronica ostruttiva (BPCO)]
    361. Ethylene oxide allergy in dialysis patients
    362. Prevalence of Hymenoptera sensitivity in Italy
    363. New therapeutic approaches in atopic dermatitis
    364. The fate of specific immunotherapy
    365. Severe adverse reactions during specific subcutaneous immunotherapy
    366. Systemic contact dermatitis to copper-containing IUD
    367. [The role of dust mites in the determination of perpetual respiratory disease, RUOLO DEGLI ACARI DELLA POLVERE NEL DETERMINISMO DI PATOLOGIE RESPIRATORIE PERENNI]

I dati visualizzati nella sezione sono recuperati dalla Procedura Gestione Carriere e Stipendi del Personale (CSA), dalla Procedura Gestione Studenti (ESSE3), da Iris e dal Sito Docenti MIUR.

Argomenti Correlati

  • Segui Unime su:
  • istagram32x32.jpg
  • facebook
  • youtube
  • twitter
  • UnimeMobile
  • tutti